Skip to content

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF AYURVEDIC DRUG MADHUKA INDICA IN PATIENTS SUFFERING FROM LOW SPERM COUNT

A RANDOMISED OPEN LABELLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF MADHUKA INDICA IN KSHEENA SHUKRA (SHUKRA KSHAYA) WITH SPECIAL REFERENCE TO OLIGOSPERMIA

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018627
Enrollment
60
Registered
2019-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: N00-N99- Diseases of the genitourinary system

Interventions

Intervention1: Oral Medication: Madhuka Pushpa Vati 3 gm twice daily for Group A for 90 days and Gokshur Vati 3 gm twice daily for Group B for 90 days Control Intervention1: Madhuka pushpa vati and G

Sponsors

VARGHESE JIBI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients presenting with Pratyatma Lakshana of Ksheena Shukra with semen samples suggestive of Oligospermia will be selected. Male patients of age ranging from 21-40 yrs Mild and Moderate oligospermia i.e. sperm count 5 mill/ml to 15 mill/ml.

Exclusion criteria

Exclusion criteria: Severe oligospermia ie Sperm count Patients with Azoospermia and Aspermia Genetic Defects like Klinefelters Syndrome Patients with disease like varicocele, Accessory sex gland infection, Sexually transmitted diseases, systemic diseases like D.M. etc

Design outcomes

Primary

MeasureTime frame
Assessment will be done according to specially designed proformaTimepoint: Treatment will be given for 90 days and eventually assessed on 30, 60 and 90 days. semen analysis will be done before enrolling and on 90th day.

Secondary

MeasureTime frame
improvement in sperm count and sexual performanceTimepoint: on 90th day

Countries

India

Contacts

Public ContactDr Varghese Jibi Thankachan

Parul University

dr.vaishalid@gmail.com919096082950

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026